Abstract
Background: Craniosynostosis, the premature fusion of one or more of the cranial sutures, is estimated to occur in 1:1800 to 2500 births. Genetic murine models of craniosynostosis exist, but often imperfectly model human patients. Case, cohort, and surveillance studies have identified excess thyroid hormone as an agent that can either cause or exacerbate human cases of craniosynostosis. Methods: Here we investigate the influence of in utero and in vitro exogenous thyroid hormone exposure on a murine model of craniosynostosis, Twist 1 +/−. Results: By 15 days post-natal, there was evidence of coronal suture fusion in the Twist 1 +/− model, regardless of exposure. With the exception of craniofacial width, there were no significant effects of exposure; however, the Twist 1 +/− phenotype was significantly different from the wild-type control. Twist 1 +/− cranial suture cells did not respond to thyroxine treatment as measured by proliferation, osteogenic differentiation, and gene expression of osteogenic markers. However, treatment of these cells did result in modulation of thyroid associated gene expression. Conclusion: Our findings suggest the phenotypic effects of the genetic mutation largely outweighed the effects of thyroxine exposure in the Twist 1 +/− model. These results highlight difficultly in experimentally modeling gene–environment interactions for craniosynostotic phenotypes. Birth Defects Research (Part A) 106:803–813, 2016.
Original language | English (US) |
---|---|
Pages (from-to) | 803-813 |
Number of pages | 11 |
Journal | Birth Defects Research Part A - Clinical and Molecular Teratology |
Volume | 106 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 2016 |
Keywords
- cephalometrics
- cranial suture
- craniosynostosis
- gene expression
- thyroid hormone
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Embryology
- Developmental Biology